Area of Focused Competency in Neuromuscular Medicine Approved by Royal College of Physicians and Surgeons of Canada

The Neuromuscular Disease Network for Canada (NMD4C) are pleased to announce that on May 3rd, 2022, the Royal College of Physicians and Surgeons of Canada approved an application for neuromuscular medicine to be recognized as an area of focused competency (AFC) discipline.

 

 “Our community is extremely excited to receive approval for this neuromuscular AFC. Through collaboration with clinical experts and Canadian neuromuscular fellowship program directors, this was a unified effort, the result of which contributes directly towards our goal of raising the standards of training for Canadian neuromuscular clinicians.”

  • Dr. Hernan Gonorazky, Assistant Professor, Faculty of Medicine University of Toronto Division of Neurology, Department of Paediatrics

 

This recognition is a significant step in raising the standards of care for people affected by neuromuscular diseases in Canada – prior to the approval of this AFC discipline, no dedicated credential focused solely on neuromuscular medicine existed in Canada. The AFC discipline in neuromuscular medicine establishes a national standard for training and specialist competence, provides neuromuscular fellows with additional opportunities to acquire nationally and internationally portable credentials, and will help to centralize specialty training, care, and practice by providing credentials in the highly focused area of neuromuscular practice. The Royal College’s AFC disciplines formally recognize and provide supplemental and advanced training within a specific area of medicine to enhance a clinician’s scope of practice, building on the broader disciplines of clinical specialties and subspecialties.

 

The Team Behind This Achievement

Led by Dr. Hernan Gonorazky, the NMD4C curriculum development team has been working on this Royal College AFC application over the past two years. Thanks to Drs. Aaron Izenberg, Christen Shoesmith, Kristine Chapman, Theo Mobach, Patrick Frosk, Jocelyn Zwicker, Alberto Aleman, Steven Baker, and all of the directors of Canadian neuromuscular fellowship programs who each contributed their expertise to this application, and without whose hard work this achievement would not have been possible. The NMD4C curriculum development working group are pleased to celebrate this milestone and are excited to work with the neuromuscular clinical community and the Royal College of Physicians and Surgeons towards implementing the AFC in neuromuscular medicine.

 

How to Achieve the Accreditation

The AFC in neuromuscular medicine has only recently been approved and has not yet been implemented by the Royal College. Once it is available, there are two pathways to achieve AFC credential and designation: the in-training route, through fellowships at medical schools with accredited AFC training programs, and the practice eligibility route (PER-AFC), for clinicians who have gained competence through their own practice. The PER-AFC is an application-based approval process.

For more information, please contact NMD4C communications coordinator James Davis at , or Curriculum development lead Dr. Hernan Gonorazky at .

Application for AFC in neuromuscular medicine approved by the Royal College

Read next...

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.